Hemoglobinopathies
Hemoglobinopathies are genetic issues affecting the shape or manufacturing of the hemoglobin molecule. Hemoglobin molecules include polypeptide chains whose chemical shape is genetically controlled. Different hemoglobins, as prominent through electrophoretic mobility, are alphabetically precise so as of discovery despite the fact that the primary unusual hemoglobin to be identified, sickle mobileular hemoglobin.
Some hemoglobinopathies bring about anemias which might be intense in sufferers who're homozygous however moderate in individuals who are heterozygous. Some sufferers are compound heterozygotes for two distinctive hemoglobinopathies and feature anemia of various severity. Normal human hemoglobins are tetrameric proteins composed of pairs of globin chains, every of which includes one alpha-like (α-like) chain and one beta-like (β-like) chain. Each globin chain is related to an iron-containing heme moiety. Throughout life, the synthesis of the alpha-like and the beta-like chains is balanced in order that their ratio is noticeably steady and there's no extra of both types. The precise alpha and beta-chains which might be integrated into Hb are especially regulated all through development
- History of Hemoglobinopathy Screening
- Types of Specimens for Hemoglobinopathy Screening and Diagnosis
- Methodologies for Hemoglobinopathy Screening and Diagnosis
- Method Advantages, Limitations and Testing Strategy
- Algorithms for Hemoglobinopathy Detection
- Quality Assurance for Hemoglobinopathy Screening and Testing
Related Conference of Hemoglobinopathies
Hemoglobinopathies Conference Speakers
Recommended Sessions
- Acute and Chronic Lymphocytic Leukemia
- Bone Marrow Transplantation
- Development of Hematopoietic Progenitor and Stem Cells
- Digital imaging in Hematology
- Disorders of Vascular Bleeding
- Epigenetic Mechanisms: Emerging Therapeutic Targets for Blood Disorders
- Genetics, Genomics, and Epigenetics
- Genome Editing and Cellular Therapy
- Hematologic Malignancy
- Hematology and Covid-19
- Hematology-Oncology
- Hemoglobin and Iron Metabolism
- Hemoglobinopathies
- Hemophilia
- Hemostasis and Thrombosis
- Immunology and Immunotherapies
- Multiple Myeloma and Other Plasma Cell Disorders
- Myelodysplastic and Myeloproliferative Disorders
- Pediatric Hematology
- Pharmacology of Chemotherapy
- Radiation Oncology or Cancer Therapy
- Transfusion Medicine
- Types of Blood Disorders
Related Journals
Are you interested in
- Biomarkers in Hematology and Oncology - Hematology Congress 2026 (Germany)
- Blood Disorders: Diagnosis and Treatment - Hematology Congress 2026 (Germany)
- Cancer Genomics & Metabolomics - Hematology Congress 2026 (Germany)
- Case Reports in Hematology - Hematology Congress 2026 (Germany)
- Clinical Haematology - Hematology Congress 2026 (Germany)
- Cord Blood Transplantation - Hematology Congress 2026 (Germany)
- Digital Imaging in Hematology - Hematology Congress 2026 (Germany)
- Haematology and Pharma Industry - Hematology Congress 2026 (Germany)
- Hematologic Cancers - Hematology Congress 2026 (Germany)
- Hematology and Cardio-Oncology - Hematology Congress 2026 (Germany)
- Hematology Nursing - Hematology Congress 2026 (Germany)
- Hematology: Diagnostics and Screening - Hematology Congress 2026 (Germany)
- Hematopoietic Malignancies - Hematology Congress 2026 (Germany)
- Immunohematology - Hematology Congress 2026 (Germany)
- Neuro-Hematology - Hematology Congress 2026 (Germany)
- Organ Specific Cancer - Hematology Congress 2026 (Germany)
- Pediatric Hematology - Hematology Congress 2026 (Germany)
- Stem Cell Therapy - Hematology Congress 2026 (Germany)
- Transfusion Medicines - Hematology Congress 2026 (Germany)
- Vascular Bleeding Disorders - Hematology Congress 2026 (Germany)
